LIREZID

Medicinal product

(Invented) name

LIREZID

Active substance (s)

Lorazepamas

Strength

4 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05BA06, Lorazepam

Marketing authorisation holder

Medochemie Ltd., Kipras

Date of authorisation

2019-09-12

Date of renewal

2024-02-07

Documents

4435 Pakuotės lapelis 2025 02 21.docx

4435 LIREZID PCS PL 2025 02 21.docx

Stage

Perregistruotas

Controlled?

Yes

Controlled substance type

Psichotropinis

Legal basis

10(1)

Procedure number

NL/H/4352/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Ampulėje (1 ml) tirpalo yra:	1 ml
Lorazepamas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102361	88461	1088461	ampulė	1 ml N5		Receptinis	LT/1/19/4435/001	Netiekiama	-	-	No	-	-
102362	88462	1088462	ampulė	1 ml N10		Receptinis	LT/1/19/4435/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2024-02-07	Perregistruotas
2019-09-12	Registruotas